BioCatalyst

Ziltivekimab — catalyst calendar

2 verified catalyst event(s) referencing Ziltivekimab, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-01
in 2mo
ESTIMATED
 READOUT
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Part
Phase 3 · Heart Failure, Systemic Inflammation
 NVO NOVO NORDISK A S Ziltivekimab ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-12-14
in 4mo
ESTIMATED
 READOUT
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo
Phase 3 · Cardiovascular Risk, Acute Myocardial Infarction (AMI)
 NVO NOVO NORDISK A S Ziltivekimab ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.